Finally, obesity influences various signaling pathways and vasoactive mediators next to MPO that have not been investigated and might contribute to PVAT phenotype, expression profile, and endothelial dysfunction. The gene discussed is MPO; the disease is obesity due to melanocortin 4 receptor deficiency.